Evidence map›Paper›PMID 37628015›Full record

ArticleFoods (Basel, Switzerland)2023

Bioavailability Assessment of an Iron Formulation Using Differentiated Human Intestinal Caco-2 Cells.

Melissa Fanzaga, Carlotta Bollati, Giulia Ranaldi, Sabrina Sucato, Silvia Fustinoni, Gabriella Roda, Carmen Lammi

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Melissa FanzagaDepartment of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, 20133 Milan, Italy.ORCID 0009-0002-3175-924X
Carlotta BollatiDepartment of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, 20133 Milan, Italy.ORCID 0000-0002-5698-1325
Giulia RanaldiCREA-Research Centre for Food and Nutrition, Via Ardeatina, 546, 00178 Rome, Italy.ORCID 0000-0002-6889-144X
Sabrina SucatoDepartment of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
Silvia FustinoniDepartment of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.ORCID 0000-0002-0287-7338
Gabriella RodaDepartment of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, 20133 Milan, Italy.
Carmen LammiDepartment of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, 20133 Milan, Italy.ORCID 0000-0002-7428-4486

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, there has been growing interest in exploring alternative and innovative delivery systems to improve the efficacy of iron supplements, satisfying iron needs and lowering side effects. To address this issue, this study aimed at demonstrating the advantages of Ferro Supremo formulation (composed of encapsulated iron, vitamins, and micronutrients), in terms of capacity to improve iron intestinal absorption, in comparison with standard FeSO

Indexed as

absorptionCaco-2 cellsdietary supplementfood ironTEERtrans-epithelial transport

Identifiers

PMID37628015
PMCPMC10453055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.